These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6810534)

  • 1. [Production of monospecific type A botulinum toxin and antiserum using a column chromatographic method].
    Marchev N; Marcheva D
    Vet Med Nauki; 1982; 19(1):57-63. PubMed ID: 6810534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production of a homogeneous Cl. botulinum type B neurotoxin].
    Saprykina TP; Kliucheva VV; Blagoveshchenskiĭ VA; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):86-91. PubMed ID: 6778041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and crystallization of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Jpn J Vet Res; 1972 Jun; 20(1):19-30. PubMed ID: 4628910
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of L-glutamate decarboxylase from rabbit brain and preparation of a monospecific antiserum.
    Brandon C
    J Neurosci Res; 1986; 15(3):367-81. PubMed ID: 2422389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified purification method for Clostridium botulinum type E toxin.
    Giménez JA; Sugiyama H
    Appl Environ Microbiol; 1987 Dec; 53(12):2827-30. PubMed ID: 3435146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of heterologous component IIs of botulinum C2 toxin.
    Ohishi I; Hama Y
    Microbiol Immunol; 1992; 36(3):221-9. PubMed ID: 1376392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris.
    Byrne MP; Titball RW; Holley J; Smith LA
    Protein Expr Purif; 2000 Apr; 18(3):327-37. PubMed ID: 10733887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Miyazaki S; Sakaguchi G
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9).
    Kawachi-Takahashi S; Tanaka K; Takahashi M
    Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood retinol-binding protein: its isolation and properties].
    Nikitin SA
    Vopr Pitan; 1982; (2):39-41. PubMed ID: 7201208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
    Gerlach D; Knöll H; Köhler W
    Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.